Benzinga’s Top Downgrades

Courtesy of Benzinga.

• Analysts at JP Morgan downgraded Esperion Therapeutics Inc (NASDAQ: ESPR) from Overweight to Neutral. The price target for Esperion Therapeutics has been lowered from $50 to $15. Esperion Therapeutics shares fell 32.51 percent to $10.92 in pre-market trading.
• Analysts at Wells Fargo downgraded HeartWare International Inc (NASDAQ: HTWR) from Outperform to Market Perform. Heartware shares closed at $57.55 on Tuesday.
• Goldman Sachs downgraded PBF Energy Inc (NYSE: PBF) from Buy to Neutral. The price target for PBF Energy has been lowered from $37 to $26. PBF Energy shares slipped 0.04 percent to $23.28 in pre-market trading.
• Analysts at Bank of America downgraded Lincoln National Corporation (NYSE: LNC) from Buy to Neutral. Lincoln National shares rose 0.33 percent to $36.89 in pre-market trading.
• Susquehanna downgraded COMSCORE, Inc. (NASDAQ: SCOR) from Positive to Neutral. comScore shares closed at $23.83 on Tuesday.
• Evercore ISI Group downgraded Oceaneering International (NYSE: OII) from Buy to Hold. Oceaneering International shares closed at $28.62 on Tuesday.
• RBC Capital downgraded Metaldyne Performance Group Inc (NYSE: MPG) from Outperform to Sector Perform. Metaldyne Performance Group shares closed at $13.62 on Tuesday.
• Bank of America downgraded Principal Financial Group Inc (NYSE: PFG) from Buy to Neutral. Principal Financial shares gained 0.10 percent to $39.10 in pre-market trading.
• Analysts at Barclays downgraded AEGON N.V. (ADR) (NYSE: AEG) from Equal-weight to Underweight. Aegon shares fell 1.98 percent to $3.96 in pre-market trading.

Posted-In: Top DowngradesDowngrades Analyst Ratings